JK

Jayamma Keshavaiah

Active Director Designated Partner DIN 06892675
DIN 06892675 First appointment Aug 2014 Primary industry Service
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayamma Keshavaiah

Data last updated:

Jayamma Keshavaiah is a Designated Partner at Diathy Clinic & Hormone Research Institute Llp (since 2014). The company operates in Service.

DIN 06892675
Primary Designation Designated Partner
Industry Service
First Appointment 25 Aug 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Aug 20142014Active

Board colleagues of Jayamma Keshavaiah

NameDINCompanyDesignation
Praveen Ramachandra02711140Diathy Clinic & Hormone Research Institute LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Diathy Clinic & Hormone Research Institute Llp
Premium access

Shareholding and investment profile for Jayamma Keshavaiah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayamma Keshavaiah

Jayamma Keshavaiah currently holds 1 directorship: Diathy Clinic & Hormone Research Institute Llp (Designated Partner, since 25 Aug 2014).

Jayamma Keshavaiah was first appointed on 25 Aug 2014 as Designated Partner at Diathy Clinic & Hormone Research Institute Llp.

The current boards of Jayamma Keshavaiah's companies include Praveen Ramachandra (Diathy Clinic & Hormone Research Institute Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available